Barclays’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-33,172
Closed -$10K 4679
2019
Q2
$10K Sell
33,172
-12,499
-27% -$3.77K ﹤0.01% 4024
2019
Q1
$211K Buy
45,671
+45,259
+10,985% +$209K ﹤0.01% 3013
2018
Q4
$1K Sell
412
-66,489
-99% -$161K ﹤0.01% 4061
2018
Q3
$675K Sell
66,901
-40,380
-38% -$407K ﹤0.01% 2490
2018
Q2
$776K Buy
107,281
+46,394
+76% +$336K ﹤0.01% 2019
2018
Q1
$369K Buy
60,887
+2,123
+4% +$12.9K ﹤0.01% 2483
2017
Q4
$566K Buy
58,764
+53,679
+1,056% +$517K ﹤0.01% 1993
2017
Q3
$45K Buy
5,085
+2,953
+139% +$26.1K ﹤0.01% 2981
2017
Q2
$27K Sell
2,132
-18,895
-90% -$239K ﹤0.01% 3195
2017
Q1
$220K Buy
21,027
+6,784
+48% +$71K ﹤0.01% 2439
2016
Q4
$132K Buy
14,243
+11,534
+426% +$107K ﹤0.01% 2498
2016
Q3
$32K Buy
+2,709
New +$32K ﹤0.01% 2890
2016
Q2
Sell
-5,377
Closed -$81K 4003
2016
Q1
$81K Buy
5,377
+4,329
+413% +$65.2K ﹤0.01% 2387
2015
Q4
$28K Sell
1,048
-184,305
-99% -$4.92M ﹤0.01% 2638
2015
Q3
$5.19M Buy
185,353
+92,963
+101% +$2.6M 0.01% 691
2015
Q2
$3.23M Buy
92,390
+90,894
+6,076% +$3.18M ﹤0.01% 984
2015
Q1
$43K Sell
1,496
-1,926
-56% -$55.4K ﹤0.01% 2819
2014
Q4
$72K Sell
3,422
-4,628
-57% -$97.4K ﹤0.01% 2839
2014
Q3
$153K Sell
8,050
-8,078
-50% -$154K ﹤0.01% 2433
2014
Q2
$250K Buy
16,128
+4,478
+38% +$69.4K ﹤0.01% 2290
2014
Q1
$239K Buy
11,650
+5,488
+89% +$113K ﹤0.01% 2296
2013
Q4
$77K Buy
6,162
+5,598
+993% +$70K ﹤0.01% 3173
2013
Q3
$6K Sell
564
-231
-29% -$2.46K ﹤0.01% 3766
2013
Q2
$4K Buy
+795
New +$4K ﹤0.01% 4126